Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Characterization of Patients With Geographic Atrophy (GA) in the US

Authors not listed

Boehringer Ingelheim · 2023

Abstract

To quantify and describe patients with a Geographic Atrophy (GA) diagnosis in at least one eye, and the progression to neovascular Age-Related Macular Degeneration (including how many receive Anti-VEGF), or to GA (in the fellow eye only).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-09 MST

Cite this

APA
Anonymous. (2023). Characterization of Patients With Geographic Atrophy (GA) in the US. <em>Boehringer Ingelheim</em>. https://clinicaltrials.gov/study/NCT05891275
Vancouver
Anonymous. Characterization of Patients With Geographic Atrophy (GA) in the US. Boehringer Ingelheim. 2023.
BibTeX
@misc{anon2023Charac, title = {Characterization of Patients With Geographic Atrophy (GA) in the US}, author = {Anonymous}, journal = {Boehringer Ingelheim}, year = {2023}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings